1
EXHIBIT (11)
STATEMENT REGARDING COMPUTATION OF EARNINGS PER SHARE
DURAMED PHARMACEUTICALS, INC.
Three months ended Six months ended
June 30, June 30,
1995 1994 1995 1994
--------------------------- ---------------------------
Primary:
Weighted average common shares
outstanding 8,012,287 7,787,756 7,998,260 7,755,920
Net effect of preferred shars
converted to common shares -
based on the treasury stock
method using the average
market price 746,590 669,100 746,590 662,073
Net effect of dilutive stock
options and warrants - based
on the treasury stock method
using the average market price 1,940,198 1,540,859 1,960,288 1,530,556
----------- ----------- ------------ -----------
Totals 10,699,075 9,997,715 10,705,138 9,948,549
=========== =========== ============ ===========
Net income $ 632,483 $ 1,453,690 $ 1,640,830 $ 2,694,727
=========== =========== ============ ===========
Per share amount $ .06 $ .15 $ .15 $ .27
=========== =========== ============ ===========
Fully diluted:
Weighted average common
shares outstanding 8,012,287 7,787,756 7,998,260 7,755,920
Net effect of preferred shares
converted to common shares -
based on the treasury stock
method using the quarter-end
market price 746,590 679,809 746,590 679,809
Net effect of dilute stock
options and warrants - based
on the treasury stock method
using the quarter-average market
price 1,940,198 1,594,385 1,961,575 1,619,267
----------- ----------- ------------ -----------
Totals 10,699,075 10,061,950 10,706,425 10,054,996
=========== =========== ============ ===========
Net income $ 632,483 $ 1,453,690 $ 1,640,830 $ 2,694,727
=========== =========== ============ ===========
Per share amount $ .06 $ .14 $ .15 $ .27
=========== =========== ============ ===========